Literature DB >> 19853559

Arrestin development: emerging roles for beta-arrestins in developmental signaling pathways.

Jeffrey J Kovacs1, Makoto R Hara, Chandra L Davenport, Jihee Kim, Robert J Lefkowitz.   

Abstract

Arrestins were identified as mediators of G protein-coupled receptor (GPCR) desensitization and endocytosis. However, it is now clear that they scaffold many intracellular signaling networks to modulate the strength and duration of signaling by diverse types of receptors--including those relevant to the Hedgehog, Wnt, Notch, and TGFbeta pathways--and downstream kinases such as the MAPK and Akt/PI3K cascades. The involvement of arrestins in many discrete developmental signaling events suggests an indispensable role for these multifaceted molecular scaffolds.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19853559      PMCID: PMC3221601          DOI: 10.1016/j.devcel.2009.09.011

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  172 in total

Review 1.  beta-arrestins: traffic cops of cell signaling.

Authors:  Robert J Lefkowitz; Erin J Whalen
Journal:  Curr Opin Cell Biol       Date:  2004-04       Impact factor: 8.382

2.  Differential kinetic and spatial patterns of beta-arrestin and G protein-mediated ERK activation by the angiotensin II receptor.

Authors:  Seungkirl Ahn; Sudha K Shenoy; Huijun Wei; Robert J Lefkowitz
Journal:  J Biol Chem       Date:  2004-06-17       Impact factor: 5.157

Review 3.  The Wnt signaling pathway in development and disease.

Authors:  Catriona Y Logan; Roel Nusse
Journal:  Annu Rev Cell Dev Biol       Date:  2004       Impact factor: 13.827

Review 4.  Physiological roles of G protein-coupled receptor kinases and arrestins.

Authors:  Richard T Premont; Raul R Gainetdinov
Journal:  Annu Rev Physiol       Date:  2007       Impact factor: 19.318

5.  Drosophila PI3 kinase and Akt involved in insulin-stimulated proliferation and ERK pathway activation in Schneider cells.

Authors:  Sung-Eun Kim; Jae-Young Cho; Kyung-Sup Kim; Su-Jae Lee; Ki-Hoo Lee; Kang-Yell Choi
Journal:  Cell Signal       Date:  2004-11       Impact factor: 4.315

Review 6.  WNT and beta-catenin signalling: diseases and therapies.

Authors:  Randall T Moon; Aimee D Kohn; Giancarlo V De Ferrari; Ajamete Kaykas
Journal:  Nat Rev Genet       Date:  2004-09       Impact factor: 53.242

7.  Orpk mouse model of polycystic kidney disease reveals essential role of primary cilia in pancreatic tissue organization.

Authors:  David A Cano; Noel S Murcia; Gregory J Pazour; Matthias Hebrok
Journal:  Development       Date:  2004-07       Impact factor: 6.868

8.  Identification of beta-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-kappaB pathways.

Authors:  Hua Gao; Yue Sun; Yalan Wu; Bing Luan; Yaya Wang; Bin Qu; Gang Pei
Journal:  Mol Cell       Date:  2004-05-07       Impact factor: 17.970

Review 9.  The IGF-I signaling pathway.

Authors:  Luigi Laviola; Annalisa Natalicchio; Francesco Giorgino
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

10.  Deltex acts as a positive regulator of Notch signaling through interactions with the Notch ankyrin repeats.

Authors:  K Matsuno; R J Diederich; M J Go; C M Blaumueller; S Artavanis-Tsakonas
Journal:  Development       Date:  1995-08       Impact factor: 6.868

View more
  96 in total

Review 1.  Serotonin receptor signaling and regulation via β-arrestins.

Authors:  Laura M Bohn; Cullen L Schmid
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-10-07       Impact factor: 8.250

Review 2.  β-Arrestins: multifunctional signaling adaptors in type 2 diabetes.

Authors:  Xiaotao Feng; Wenjian Wang; Jibo Liu; Yi Liu
Journal:  Mol Biol Rep       Date:  2010-11-18       Impact factor: 2.316

3.  Arrestin-2 differentially regulates PAR4 and ADP receptor signaling in platelets.

Authors:  Dongjun Li; Lauren D'Angelo; Massiel Chavez; Donna S Woulfe
Journal:  J Biol Chem       Date:  2010-11-24       Impact factor: 5.157

4.  A novel KRAB domain-containing zinc finger transcription factor ZNF431 directly represses Patched1 transcription.

Authors:  Zhenhua He; Jing Cai; Jong-Won Lim; Kristen Kroll; Liang Ma
Journal:  J Biol Chem       Date:  2010-12-21       Impact factor: 5.157

5.  β-Arrestin2 mediates the initiation and progression of myeloid leukemia.

Authors:  Mark Fereshteh; Takahiro Ito; Jeffrey J Kovacs; Chen Zhao; Hyog Young Kwon; Valerie Tornini; Takaaki Konuma; Minyong Chen; Robert J Lefkowitz; Tannishtha Reya
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-05       Impact factor: 11.205

6.  Role of Runx2 in IGF-1Rβ/Akt- and AMPK/Erk-dependent growth, survival and sensitivity towards metformin in breast cancer bone metastasis.

Authors:  M Tandon; Z Chen; A H Othman; J Pratap
Journal:  Oncogene       Date:  2016-01-25       Impact factor: 9.867

7.  A negative allosteric modulator demonstrates biased antagonism of the follicle stimulating hormone receptor.

Authors:  James A Dias; Béatrice Bonnet; Barbara A Weaver; Julie Watts; Kerri Kluetzman; Richard M Thomas; Sonia Poli; Vincent Mutel; Brice Campo
Journal:  Mol Cell Endocrinol       Date:  2010-12-22       Impact factor: 4.102

8.  Essential requirement for β-arrestin2 in mouse intestinal tumors with elevated Wnt signaling.

Authors:  Caroline Bonnans; Maud Flacelière; Fanny Grillet; Christelle Dantec; Jean-Pierre Desvignes; Julie Pannequin; Dany Severac; Emeric Dubois; Frédéric Bibeau; Virginie Escriou; Philippe Crespy; Laurent Journot; Frédéric Hollande; Dominique Joubert
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-06       Impact factor: 11.205

Review 9.  The emerging roles of β-arrestins in fibrotic diseases.

Authors:  Yuan-jing Gu; Wu-yi Sun; Sen Zhang; Jing-jing Wu; Wei Wei
Journal:  Acta Pharmacol Sin       Date:  2015-09-21       Impact factor: 6.150

10.  Effects of cocaine and withdrawal on the mouse nucleus accumbens transcriptome.

Authors:  J E Eipper-Mains; D D Kiraly; M O Duff; M J Horowitz; C J McManus; B A Eipper; B R Graveley; R E Mains
Journal:  Genes Brain Behav       Date:  2012-11-27       Impact factor: 3.449

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.